[1]
M. M. . Ali and N. M. A. Mahmood, “The Use of Cyclin-Dependent Tyrosine Kinase 4/6 (CDK4/6) Inhibitors in Breast Cancer”, Al-Rafidain J Med Sci, vol. 3, pp. 30–35, Sep. 2022.